It's rare these days for an artist to ask for fewer microphones, but after warming up in our space, Billy Strings did just that. Surrounded by his band, the bluegrass virtuoso brings back the spirit ...
Michigan bluegrass phenom Billy Strings and his band stopped by NPR’s Tiny Desk for a performance more than a decade in the making. Backed by his band — Alex Hargreaves on fiddle, backing vocalist ...
Strings will be performing at the Fishers Event Center on Friday, April 24 and Saturday, April 25, 2026. The tour extension is in support of his latest full-length album, "Highway Prayers, which was ...
After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...
The bluegrass musician's mom Debra died of a drug overdose in June Rachel DeSantis is a senior writer on the music team at PEOPLE. She has been working at PEOPLE since 2019, and her work has ...
Billy Strings is opening up about the unexpected death of his mother, Debra Apostal, which happened in June. Strings — whose legal name is William Lee Apostal — says his mom wasn't sick leading up to ...
Sharing some heartbreaking news regarding his mother’s unexpected death. Earlier this summer, Billy Strings, whose real name is William Lee Apostol, informed the world that his mother tragically ...
Billy Strings revealed that he wants to set his late mother’s poetry to music for a potential new album during an extensive interview about drug use and addiction on the Dopey podcast. Strings’ mother ...
Billy Strings Performs “Leaning On A Travelin’ Song” On ‘The Late Show With Stephen Colbert’ [Watch]
[Update 11/20/25]: Billy Strings appeared on The Late Show with Stephen Colbert on Thursday night for a performance of “Leaning on a Travelin’ Song”, the opening track from his Grammy Award-nominated ...
After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...
Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...
Recursion Pharmaceuticals remains a high-cash-burn, premium-valued biotech with unproven clinical success despite a recent 47% rally. RXRX's next 18 months are catalyst-rich, but key pipeline assets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback